Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001047469-05-006537
Filing Date
2005-03-15
Accepted
2005-03-15 16:20:32
Documents
16
Period of Report
2004-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K a2152822z10-k.htm 10-K 727812
2 EXHIBIT 4.5 a2152822zex-4_5.txt EX-4.5 36449
3 EXHIBIT 10.50 a2152822zex-10_50.txt EX-10.50 6031
4 EXHIBIT 10.53 a2152822zex-10_53.txt EX-10.53 2678
5 EXHIBIT 10.54 a2152822zex-10_54.txt EX-10.54 2989
6 EXHIBIT 10.60 a2152822zex-10_60.txt EX-10.60 9622
7 EXHIBIT 10.61 a2152822zex-10_61.txt EX-10.61 2593
8 EX-10.62 a2152822zex-10_62.txt EX-10.62 5307
9 EXHIBIT 10.63 a2152822zex-10_63.txt EX-10.63 7786
10 EX-10.65 a2152822zex-10_65.txt EX-10.65 5056
11 EXHIBIT 21.1 a2152822zex-21_1.txt EX-21.1 237
12 EX-23.1 a2152822zex-23_1.htm EX-23.1 2592
13 EXHIBIT 31.1 a2152822zex-31_1.htm EX-31.1 6066
14 EXHIBIT 31.2 a2152822zex-31_2.htm EX-31.2 6087
15 EXHIBIT 32.1 a2152822zex-32_1.htm EX-32.1 2727
16 EXHIBIT 32.2 a2152822zex-32_2.htm EX-32.2 2723
  Complete submission text file 0001047469-05-006537.txt   830107
Mailing Address FIVE SCIENCE PARK NEW HAVEN CT 06511
Business Address FIVE SCIENCE PARK NEW HAVEN CT 06511 2037731450
GENAISSANCE PHARMACEUTICALS INC (Filer) CIK: 0001110009 (see all company filings)

EIN.: 061338846 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-30981 | Film No.: 05681951
SIC: 8731 Services-Commercial Physical & Biological Research